Salarius Pharmaceuticals, Inc. (SLRX)
NASDAQ: SLRX · Real-Time Price · USD
0.9250
+0.0423 (4.79%)
At close: Nov 26, 2025, 4:00 PM EST
0.8854
-0.0396 (-4.28%)
After-hours: Nov 26, 2025, 7:59 PM EST
Salarius Pharmaceuticals Market Cap
Salarius Pharmaceuticals has a market cap or net worth of $5.42 million as of November 26, 2025. Its market cap has increased by 150.84% in one year.
Market Cap
5.42M
Enterprise Value
612.84K
1-Year Change
150.84%
Ranking
Category
Stock Price
$0.93
Market Cap Chart
Since July 22, 2019, Salarius Pharmaceuticals's market cap has decreased from $44.21M to $5.42M, a decrease of -87.74%. That is a compound annual growth rate of -28.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 5.42M | 104.49% |
| Dec 31, 2024 | 2.65M | 3.58% |
| Dec 29, 2023 | 2.56M | -26.56% |
| Dec 30, 2022 | 3.49M | -84.44% |
| Dec 31, 2021 | 22.40M | 3.42% |
| Dec 31, 2020 | 21.66M | 41.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 22, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 287.99B |
| Merck & Co. | 259.69B |
| Novartis AG | 249.49B |
| Abbott Laboratories | 223.51B |